
    
      Seventy patients with irritable bowel syndrome (IBS) will be randomized to either 1) placebo
      pill or 2) no treatment and followed for 3 weeks. The study will involve three visits:
      baseline, midpoint and end point. At baseline all patients will physical examination, be
      evaluated for IBS and be administered standardized IBS questionnaires including: "IBS
      adequate relief" questionnaire, IBS global symptom improvement scale, IBS quality of life and
      IBS symptom severity scale. At midpoint and endpoint the same questionnaires will be
      administered. Patients on no treatment will be offered education on managing IBS at the end
      of the study.
    
  